Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eicosanoids | 15 | 2023 | 284 | 4.890 |
Why?
|
Epoxide Hydrolases | 13 | 2024 | 122 | 3.290 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2018 | 1495 | 1.320 |
Why?
|
Neoplasms | 22 | 2024 | 22389 | 1.250 |
Why?
|
Inflammation | 16 | 2024 | 10868 | 1.080 |
Why?
|
Neoplasms, Experimental | 6 | 2019 | 1231 | 1.060 |
Why?
|
Neoplasm Metastasis | 8 | 2021 | 4926 | 0.970 |
Why?
|
Neovascularization, Pathologic | 18 | 2023 | 2634 | 0.950 |
Why?
|
Docosahexaenoic Acids | 5 | 2019 | 914 | 0.950 |
Why?
|
Cyclooxygenase 2 | 5 | 2023 | 597 | 0.930 |
Why?
|
Prostaglandins | 3 | 2023 | 398 | 0.880 |
Why?
|
Electrocardiography | 4 | 2018 | 6413 | 0.860 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 2 | 2023 | 44 | 0.830 |
Why?
|
Antineoplastic Agents | 12 | 2021 | 13698 | 0.800 |
Why?
|
Liver Regeneration | 2 | 2014 | 214 | 0.790 |
Why?
|
Cytokines | 9 | 2021 | 7453 | 0.780 |
Why?
|
Cyclooxygenase 2 Inhibitors | 4 | 2023 | 319 | 0.770 |
Why?
|
Lipid Metabolism | 4 | 2018 | 1904 | 0.710 |
Why?
|
Macrophages | 9 | 2022 | 5801 | 0.660 |
Why?
|
8,11,14-Eicosatrienoic Acid | 3 | 2017 | 64 | 0.650 |
Why?
|
Fatty Acids | 2 | 2024 | 1812 | 0.640 |
Why?
|
Ketorolac | 1 | 2019 | 95 | 0.620 |
Why?
|
Epoxy Compounds | 3 | 2013 | 137 | 0.620 |
Why?
|
Thromboxane A2 | 1 | 2018 | 87 | 0.610 |
Why?
|
Fatty Acids, Unsaturated | 4 | 2019 | 542 | 0.600 |
Why?
|
Neovascularization, Physiologic | 3 | 2014 | 1371 | 0.540 |
Why?
|
Cytochrome P-450 Enzyme System | 4 | 2011 | 423 | 0.540 |
Why?
|
Osteopontin | 1 | 2018 | 311 | 0.530 |
Why?
|
PPAR alpha | 2 | 2008 | 177 | 0.520 |
Why?
|
Angiogenesis Inhibitors | 10 | 2011 | 2059 | 0.470 |
Why?
|
Cardiotonic Agents | 1 | 2017 | 544 | 0.460 |
Why?
|
Neuropilin-1 | 1 | 2014 | 90 | 0.450 |
Why?
|
Lipids | 3 | 2023 | 3345 | 0.450 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2014 | 93 | 0.450 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3952 | 0.440 |
Why?
|
Animals | 53 | 2024 | 169335 | 0.430 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1560 | 0.430 |
Why?
|
Fluorouracil | 1 | 2018 | 1655 | 0.420 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2014 | 1399 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.410 |
Why?
|
Wound Healing | 2 | 2014 | 2815 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
Mice | 39 | 2024 | 82072 | 0.400 |
Why?
|
Algorithms | 3 | 2018 | 14201 | 0.400 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2276 | 0.390 |
Why?
|
Aflatoxin B1 | 2 | 2022 | 17 | 0.390 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2027 | 0.380 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4919 | 0.380 |
Why?
|
Epidermis | 1 | 2014 | 539 | 0.370 |
Why?
|
Inflammation Mediators | 4 | 2023 | 1890 | 0.370 |
Why?
|
Databases as Topic | 3 | 2018 | 475 | 0.360 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1811 | 0.360 |
Why?
|
Carcinoma, Lewis Lung | 5 | 2013 | 108 | 0.350 |
Why?
|
Preoperative Care | 1 | 2019 | 2258 | 0.340 |
Why?
|
Hep G2 Cells | 2 | 2021 | 378 | 0.340 |
Why?
|
Keratinocytes | 1 | 2014 | 876 | 0.330 |
Why?
|
Phagocytosis | 3 | 2021 | 1530 | 0.330 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2543 | 0.330 |
Why?
|
Bone Remodeling | 1 | 2013 | 583 | 0.330 |
Why?
|
Fetus | 1 | 2017 | 1882 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 2 | 2016 | 2258 | 0.320 |
Why?
|
Arachidonic Acid | 7 | 2023 | 429 | 0.320 |
Why?
|
Glioma | 2 | 2022 | 3532 | 0.310 |
Why?
|
Glioblastoma | 2 | 2022 | 3525 | 0.310 |
Why?
|
Melanoma, Experimental | 4 | 2017 | 559 | 0.310 |
Why?
|
Cell Proliferation | 9 | 2022 | 10486 | 0.310 |
Why?
|
Carcinogens | 2 | 2020 | 453 | 0.300 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1798 | 0.300 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4363 | 0.290 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2848 | 0.290 |
Why?
|
Pediatrics | 2 | 2020 | 3628 | 0.290 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.290 |
Why?
|
Fenofibrate | 1 | 2008 | 87 | 0.290 |
Why?
|
Blood Platelets | 1 | 2018 | 2479 | 0.290 |
Why?
|
Mice, Inbred C57BL | 17 | 2021 | 22379 | 0.280 |
Why?
|
Signal Transduction | 10 | 2022 | 23653 | 0.280 |
Why?
|
Aspirin | 1 | 2019 | 3135 | 0.280 |
Why?
|
Atherosclerosis | 1 | 2023 | 3431 | 0.280 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2830 | 0.270 |
Why?
|
Cell Line, Tumor | 8 | 2022 | 17173 | 0.270 |
Why?
|
Endothelial Cells | 5 | 2014 | 3592 | 0.270 |
Why?
|
Humans | 56 | 2024 | 768970 | 0.260 |
Why?
|
Thiazoles | 2 | 2003 | 1542 | 0.250 |
Why?
|
MicroRNAs | 1 | 2021 | 3811 | 0.250 |
Why?
|
Granulocytes | 1 | 2007 | 551 | 0.240 |
Why?
|
Regeneration | 1 | 2013 | 1524 | 0.230 |
Why?
|
Heart Rate | 1 | 2015 | 4217 | 0.230 |
Why?
|
Cell Movement | 3 | 2015 | 5216 | 0.220 |
Why?
|
Mice, Transgenic | 5 | 2017 | 9565 | 0.210 |
Why?
|
Brain Neoplasms | 2 | 2022 | 9213 | 0.200 |
Why?
|
PPAR gamma | 1 | 2005 | 487 | 0.200 |
Why?
|
Pain | 1 | 2017 | 5100 | 0.200 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2014 | 246 | 0.190 |
Why?
|
Liver | 2 | 2014 | 7578 | 0.190 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10276 | 0.190 |
Why?
|
Cell Death | 3 | 2022 | 1682 | 0.190 |
Why?
|
Mice, Knockout | 5 | 2019 | 14484 | 0.190 |
Why?
|
Hypertension | 2 | 2020 | 8617 | 0.180 |
Why?
|
Fibroblast Growth Factor 2 | 4 | 2008 | 594 | 0.180 |
Why?
|
Neoplastic Processes | 1 | 2020 | 36 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9442 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3621 | 0.180 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2517 | 0.170 |
Why?
|
Stem Cells | 1 | 2013 | 3539 | 0.170 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 3608 | 0.170 |
Why?
|
Plasminogen Inactivators | 1 | 2019 | 37 | 0.160 |
Why?
|
Thiazolidinediones | 1 | 2002 | 461 | 0.160 |
Why?
|
Biology | 1 | 2021 | 292 | 0.160 |
Why?
|
Sesquiterpenes | 5 | 2010 | 177 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2014 | 3518 | 0.150 |
Why?
|
Glomerulonephritis | 1 | 2020 | 333 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2021 | 2336 | 0.150 |
Why?
|
Disease Models, Animal | 7 | 2020 | 18354 | 0.150 |
Why?
|
Neuroblastoma | 2 | 2020 | 1266 | 0.150 |
Why?
|
Mice, SCID | 4 | 2019 | 2631 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 859 | 0.150 |
Why?
|
Disease Progression | 4 | 2020 | 13674 | 0.150 |
Why?
|
Platinum | 1 | 2019 | 222 | 0.140 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 665 | 0.140 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 3 | 2014 | 318 | 0.140 |
Why?
|
Phenylurea Compounds | 1 | 2020 | 531 | 0.140 |
Why?
|
Cyclooxygenase 1 | 1 | 2017 | 98 | 0.140 |
Why?
|
Fuzzy Logic | 1 | 2017 | 58 | 0.140 |
Why?
|
Pandemics | 3 | 2022 | 8749 | 0.130 |
Why?
|
Phosphatidylserines | 1 | 2017 | 186 | 0.130 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 606 | 0.130 |
Why?
|
Lipoxins | 1 | 2019 | 419 | 0.130 |
Why?
|
Cyclohexanes | 5 | 2010 | 152 | 0.130 |
Why?
|
Receptor, TIE-2 | 2 | 2014 | 183 | 0.130 |
Why?
|
Normal Distribution | 1 | 2016 | 272 | 0.130 |
Why?
|
Lipoxygenases | 2 | 2014 | 13 | 0.130 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2016 | 133 | 0.120 |
Why?
|
Taxoids | 1 | 2019 | 668 | 0.120 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 255 | 0.120 |
Why?
|
Chemokines | 1 | 2019 | 963 | 0.120 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2018 | 647 | 0.120 |
Why?
|
Ischemia | 1 | 2023 | 1900 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2022 | 1356 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3629 | 0.110 |
Why?
|
Apoptosis | 3 | 2020 | 9527 | 0.110 |
Why?
|
Tumor Burden | 2 | 2017 | 1913 | 0.110 |
Why?
|
Vasoconstriction | 1 | 2016 | 593 | 0.110 |
Why?
|
Microtubule-Associated Proteins | 1 | 2019 | 1074 | 0.110 |
Why?
|
Reperfusion Injury | 1 | 2020 | 1036 | 0.110 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6131 | 0.110 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2014 | 1057 | 0.110 |
Why?
|
Organotechnetium Compounds | 1 | 2013 | 133 | 0.110 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3057 | 0.100 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.100 |
Why?
|
Integrin alphaVbeta3 | 1 | 2013 | 103 | 0.100 |
Why?
|
Medicine | 1 | 2021 | 947 | 0.100 |
Why?
|
Blotting, Northern | 1 | 2014 | 1553 | 0.100 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11116 | 0.100 |
Why?
|
Endothelium, Vascular | 5 | 2012 | 4428 | 0.100 |
Why?
|
Receptors, Eicosanoid | 1 | 2011 | 12 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1667 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1794 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 178 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1930 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 930 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1575 | 0.090 |
Why?
|
Epithelium | 1 | 2016 | 1607 | 0.090 |
Why?
|
Cell Line | 4 | 2020 | 15604 | 0.090 |
Why?
|
Peptides, Cyclic | 1 | 2013 | 391 | 0.090 |
Why?
|
Retinal Neovascularization | 1 | 2014 | 288 | 0.090 |
Why?
|
Anti-Infective Agents | 1 | 2018 | 984 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 597 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1904 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1803 | 0.090 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 2010 | 225 | 0.090 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6232 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3726 | 0.080 |
Why?
|
Anticarcinogenic Agents | 1 | 2011 | 251 | 0.080 |
Why?
|
Blotting, Western | 2 | 2014 | 5033 | 0.080 |
Why?
|
Colitis | 1 | 2018 | 1242 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2029 | 0.080 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 997 | 0.080 |
Why?
|
Metabolomics | 1 | 2019 | 1675 | 0.080 |
Why?
|
History, 20th Century | 1 | 2017 | 2771 | 0.080 |
Why?
|
Eye | 1 | 2013 | 712 | 0.080 |
Why?
|
Artifacts | 1 | 2018 | 1942 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2149 | 0.080 |
Why?
|
Male | 20 | 2021 | 365203 | 0.080 |
Why?
|
Ligands | 2 | 2008 | 3283 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 384 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8055 | 0.070 |
Why?
|
Fish Oils | 1 | 2011 | 483 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1936 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1907 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1141 | 0.070 |
Why?
|
Immunotherapy | 1 | 2024 | 4756 | 0.070 |
Why?
|
Collagen | 3 | 2013 | 2646 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2016 | 1945 | 0.070 |
Why?
|
Sucrose | 1 | 2008 | 157 | 0.070 |
Why?
|
Radiation Chimera | 1 | 2007 | 216 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.070 |
Why?
|
Polymers | 1 | 2014 | 1632 | 0.070 |
Why?
|
Cattle | 5 | 2008 | 3819 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4413 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 800 | 0.070 |
Why?
|
Hematopoiesis | 1 | 2015 | 2059 | 0.060 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 867 | 0.060 |
Why?
|
RNA Interference | 1 | 2014 | 2835 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1125 | 0.060 |
Why?
|
Thrombospondin 1 | 1 | 2007 | 257 | 0.060 |
Why?
|
Corneal Neovascularization | 1 | 2007 | 184 | 0.060 |
Why?
|
Endothelium | 1 | 2008 | 768 | 0.060 |
Why?
|
Base Sequence | 2 | 2014 | 12430 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3433 | 0.060 |
Why?
|
Survival Rate | 2 | 2018 | 12873 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8544 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2603 | 0.060 |
Why?
|
Cell Division | 5 | 2008 | 4478 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17629 | 0.060 |
Why?
|
Cornea | 3 | 2008 | 1315 | 0.060 |
Why?
|
Zebrafish | 1 | 2015 | 3037 | 0.060 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2023 | 48 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5443 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1836 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6512 | 0.050 |
Why?
|
Macular Degeneration | 1 | 2010 | 1016 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3408 | 0.050 |
Why?
|
Transcription Factors | 1 | 2002 | 12174 | 0.050 |
Why?
|
Nanoparticles | 1 | 2014 | 1989 | 0.050 |
Why?
|
Leukotrienes | 1 | 2023 | 232 | 0.050 |
Why?
|
Drug Synergism | 2 | 2017 | 1762 | 0.050 |
Why?
|
Endothelial Growth Factors | 2 | 2001 | 674 | 0.050 |
Why?
|
Kidney | 2 | 2015 | 7058 | 0.050 |
Why?
|
Organic Chemicals | 1 | 2002 | 211 | 0.050 |
Why?
|
Child | 2 | 2020 | 80960 | 0.050 |
Why?
|
Lymphokines | 2 | 2001 | 927 | 0.050 |
Why?
|
Cytochalasins | 1 | 2000 | 19 | 0.050 |
Why?
|
Female | 8 | 2019 | 397515 | 0.040 |
Why?
|
Glomerular Mesangium | 1 | 2020 | 98 | 0.040 |
Why?
|
Dinoprostone | 1 | 2023 | 597 | 0.040 |
Why?
|
Granuloma | 1 | 2022 | 329 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4064 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2004 | 718 | 0.040 |
Why?
|
Diet | 2 | 2022 | 8088 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 2414 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2016 | 11684 | 0.040 |
Why?
|
Sulindac | 1 | 1999 | 29 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2709 | 0.040 |
Why?
|
Lung | 2 | 2016 | 10099 | 0.040 |
Why?
|
Enalapril | 1 | 2020 | 317 | 0.040 |
Why?
|
Rats | 2 | 2011 | 23786 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1780 | 0.040 |
Why?
|
Triclosan | 1 | 2018 | 58 | 0.040 |
Why?
|
Thrombopoietin | 1 | 1999 | 226 | 0.040 |
Why?
|
RNA, Transfer | 1 | 1999 | 284 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 30046 | 0.040 |
Why?
|
Thalidomide | 2 | 2002 | 886 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2000 | 2251 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2018 | 258 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5716 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2016 | 12806 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2004 | 957 | 0.030 |
Why?
|
Biological Transport | 2 | 2013 | 2085 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5864 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13594 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2017 | 412 | 0.030 |
Why?
|
Superoxides | 1 | 2017 | 389 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2016 | 384 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5707 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 30265 | 0.030 |
Why?
|
Cytochromes | 1 | 2014 | 18 | 0.030 |
Why?
|
Solubility | 1 | 2016 | 1087 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10765 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 587 | 0.030 |
Why?
|
Hemangioma | 1 | 1999 | 727 | 0.030 |
Why?
|
Lipoxygenase | 1 | 2014 | 72 | 0.030 |
Why?
|
Biotransformation | 1 | 2014 | 166 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2022 | 1469 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 1197 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2015 | 321 | 0.030 |
Why?
|
Penicillamine | 1 | 2013 | 60 | 0.030 |
Why?
|
Intestines | 1 | 2022 | 1911 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1514 | 0.030 |
Why?
|
Oxygen | 2 | 2016 | 4272 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2000 | 799 | 0.030 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2013 | 56 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 742 | 0.030 |
Why?
|
Androgens | 1 | 2001 | 1285 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3631 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2080 | 0.030 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 356 | 0.030 |
Why?
|
Isoenzymes | 1 | 2017 | 1687 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4592 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 1999 | 1181 | 0.020 |
Why?
|
Angiostatins | 2 | 2002 | 64 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2014 | 662 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 1009 | 0.020 |
Why?
|
Plasminogen | 2 | 2002 | 144 | 0.020 |
Why?
|
Endostatins | 2 | 2002 | 168 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3335 | 0.020 |
Why?
|
Eye Proteins | 1 | 2014 | 628 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 788 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2010 | 425 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2014 | 565 | 0.020 |
Why?
|
Integrases | 1 | 2012 | 520 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4651 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1833 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2001 | 751 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2222 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1163 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1085 | 0.020 |
Why?
|
Kinetics | 2 | 2010 | 6332 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2013 | 1680 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2012 | 874 | 0.020 |
Why?
|
Microscopy | 1 | 2013 | 910 | 0.020 |
Why?
|
Descemet Membrane | 1 | 2008 | 70 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2010 | 692 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 586 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4148 | 0.020 |
Why?
|
Hemodynamics | 1 | 2016 | 4199 | 0.020 |
Why?
|
Dietary Fats | 1 | 2014 | 2002 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2884 | 0.020 |
Why?
|
Microcirculation | 1 | 2010 | 1281 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1340 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3744 | 0.020 |
Why?
|
Capillaries | 1 | 2008 | 756 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 1943 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3775 | 0.010 |
Why?
|
Centrosome | 1 | 2004 | 210 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2063 | 0.010 |
Why?
|
Models, Biological | 1 | 1999 | 9499 | 0.010 |
Why?
|
Karyotyping | 1 | 2004 | 1177 | 0.010 |
Why?
|
Phenylbutyrates | 1 | 2002 | 72 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2008 | 1161 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7609 | 0.010 |
Why?
|
Aneuploidy | 1 | 2004 | 573 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4356 | 0.010 |
Why?
|
Mycotoxins | 1 | 2000 | 35 | 0.010 |
Why?
|
Aspergillus | 1 | 2000 | 95 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2827 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2004 | 725 | 0.010 |
Why?
|
Obesity | 1 | 2002 | 13091 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1999 | 305 | 0.010 |
Why?
|
Aminopeptidases | 1 | 2000 | 114 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1999 | 412 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13427 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2000 | 386 | 0.010 |
Why?
|
Stromal Cells | 1 | 2004 | 1337 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2525 | 0.010 |
Why?
|
Peptide Fragments | 2 | 2002 | 5151 | 0.010 |
Why?
|
Mitochondria | 1 | 2011 | 3682 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1999 | 521 | 0.010 |
Why?
|
Protein Binding | 1 | 2010 | 9344 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2001 | 11230 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2000 | 719 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11932 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 2002 | 1026 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8664 | 0.010 |
Why?
|
Platelet Count | 1 | 1999 | 787 | 0.010 |
Why?
|
Time Factors | 2 | 2011 | 40261 | 0.010 |
Why?
|
Syndrome | 1 | 1999 | 3274 | 0.010 |
Why?
|
Body Composition | 1 | 2002 | 2462 | 0.010 |
Why?
|
Rabbits | 1 | 1999 | 4774 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19023 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4628 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2002 | 2905 | 0.010 |
Why?
|
Administration, Oral | 1 | 1999 | 4040 | 0.010 |
Why?
|
Brain | 1 | 2013 | 27453 | 0.000 |
Why?
|
Middle Aged | 1 | 2016 | 223737 | 0.000 |
Why?
|